AbbVie (ABBV) Net Income (2012 - 2026)

AbbVie has disclosed Net Income across 15 years of filings, most recently posting $697.0 million for Q1 2026.

• In Q1 2026, Net Income fell 45.93% year-over-year to $697.0 million; the TTM figure through Mar 2026 stood at $3.6 billion (down 13.37% YoY), while the FY2025 annual figure was $4.2 billion, down 1.24% from the prior year.
• Net Income declined to $697.0 million in Q1 2026, from $1.8 billion in the prior quarter.
• Over the last five years, Net Income for ABBV reached as high as $4.5 billion in Q1 2022 and fell as low as -$97.0 million in Q1 2023.
• The 5-year median for Net Income is $1.4 billion (2024), against an average of $1.5 billion.
• Annual changes were most pronounced in 2024 — Net Income sank 102.79% — and 2025, when it surged 7991.3%.
• A 5-year view of Net Income shows it stood at $2.5 billion in 2022, then tumbled by 66.67% to $824.0 million in 2023, then slumped by 102.79% to -$23.0 million in 2024, then surged by 7991.3% to $1.8 billion in 2025, then sank by 61.6% to $697.0 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered $697.0 million, $1.8 billion, and $188.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.